SPX3,825.33+39.95 1.06%
DIA310.85+3.03 0.98%
IXIC11,127.85+99.11 0.90%

BRIEF-Teva Announces Settlement With Aurobindo Resolving Austedo® (Deutetrabenazine) Patent Dispute

reuters.com · 06/09/2022 17:20
BRIEF-Teva Announces Settlement With Aurobindo Resolving Austedo® (Deutetrabenazine) Patent Dispute

- Teva Pharmaceutical Industries Ltd TEVA:

  • TEVA ANNOUNCES SETTLEMENT WITH AUROBINDO RESOLVING AUSTEDO® (DEUTETRABENAZINE) PATENT DISPUTE

  • TEVA PHARMACEUTICAL - HAVE REACHED AN AGREEMENT WITH AUROBINDO TO RESOLVE DISPUTE OVER AUROBINDO'S ANDA FOR A GENERIC DEUTETRABENAZINE PRODUCT

  • TEVA PHARMACEUTICAL - UNDER TERMS OF SETTLEMENT AGREEMENT, LITIGATION BETWEEN PARTIES IN U.S. DISTRICT COURT FOR DISTRICT OF NEW JERSEY WILL BE ENDED

  • TEVA PHARMACEUTICAL INDUSTRIES LTD - UNDER SETTLEMENT, AUROBINDO WILL HAVE A LICENSE TO SELL ITS GENERIC PRODUCT BEGINNING APRIL 2033 OR EARLIER

Source text for Eikon: ID:nBw1lFm4Ra

Further company coverage: TEVA


((Reuters.Briefs@thomsonreuters.com;))